Skip to main content
SpringerLink
Log in

Alzheimer’s disease — The ways of prevention

  • Published:
The Journal of Nutrition Health and Aging

Abstract

Several vascular and lifestyle related factors have been suggested to influence the development of dementia and Alzheimer’s disease (AD), creating new prevention opportunities. This paper discusses current epidemiological evidence and new findings from the Finnish population based CAIDE study linking some of these factors to dementia/AD. Such findings provide an optimistic outlook especially for persons with genetic susceptibility; it may be possible to reduce the risk or postpone the onset of dementia by adopting healthy lifestyle options. The interplay of genes and environment in the aetiology of AD needs to be further investigated as well as the role of lifestyle and pharmacological interventions for the prevention of dementia.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Similar content being viewed by others

References

  1. Kivipelto M, Helkala EL, Laakso MP, Hanninen T, Hallikainen M, Alhainen K, Soininen H, Tuomilehto J, Nissinen A. Midlife vascular risk factors and Alzheimer’s disease in later life: longitudinal, population based study. BMJ 2001; 322(7300): 1447–51

    Article  PubMed  CAS  Google Scholar 

  2. Launer LJ, Ross GW, Petrovitch H, Masaki K, Foley D, White LR, Havlik RJ. Midlife blood pressure and dementia: the Honolulu-Asia aging study. Neurobiol Aging 2000; 21: 49–55

    Article  PubMed  CAS  Google Scholar 

  3. Kivipelto M, Helkala E-L, Laakso MP, Hänninen T, Hallikainen M, Alhainen K, Iivonen S, Mannermaa A, Tuomilehto J, Nissinen A, Soininen H. Apolipoprotein E ε4 allele, elevated midlife total cholesterol level and high midlife systolic blood pressure are independent risk factors for late-life Alzheimer’s disease. Annals of Internal Medicine 2002;137: 149–155.

    PubMed  CAS  Google Scholar 

  4. Skoog I, Lernfelt B, Landahl S et al. 15-year longitudinal study of blood pressure and dementia. Lancet 1996;347: 1141–1145

    Article  PubMed  CAS  Google Scholar 

  5. Peila R, White LR, Masaki K, Petrovitch H, Launer LJ. Reducing the risk of dementia: efficacy of long-term treatment of hypertension. Stroke 2006;37(5): 1165–70

    Article  PubMed  Google Scholar 

  6. Whitmer RA, Sidney S, Selby J, Johnston SC, Yaffe K. Midlife cardiovascular risk factors and risk of dementia in late life. Neurology. 2005;64(2): 277–81

    PubMed  CAS  Google Scholar 

  7. Launer LJ, White LR, Petrovitch H, Ross GW, Curb JD. Cholesterol and neuropathologic markers of AD: a population-based autopsy study. Neurology. 2001;57: 1447–52

    PubMed  CAS  Google Scholar 

  8. Pappolla MA, Bryant-Thomas TK, Herbert D, Pacheco J, Fabra Garcia M, Manjon M, Girones X, Henry TL, Matsubara E, Zambon D, Wolozin B, Sano M, Cruz-Sanchez FF, Thal LJ, Petanceska SS, Refolo LM. Mild hypercholesterolemia is an early risk factor for the development of Alzheimer amyloid pathology. Neurology. 2003;61(2): 199–205

    PubMed  CAS  Google Scholar 

  9. Solomon A, Kåreholt I, Ngandu T, Winbald B, Nissinen A, Tuomilehto J, Soininen H, Kivipelto M. (2007). Serum cholesterol changes after midlife and late-life cognition: 21-year follow-up study. Neurology; 68(10): 751–6

    Article  PubMed  CAS  Google Scholar 

  10. Stewart R, White LR, Xue QL, Launer LJ. Twenty-six-year change in total cholesterol levels and incident dementia: the Honolulu-Asia Aging Study. Arch Neurol. 2007;64(1): 103–7

    Article  PubMed  Google Scholar 

  11. Björhem I. Crossing the barrier: oxysterlos as cholesterol transporters and metabolic modulators in the brain. J Int Med 2006; 260: 493–508

    Article  Google Scholar 

  12. Sparks DL, Scheff SW, Hunsaker JC 3rd, Liu H, Landers T, Gross DR. Induction of Alzheimer-like beta-amyloid immunoreactivity in the brains of rabbits with dietary cholesterol. Exp Neurol. 1994;126(1): 88–94

    Article  PubMed  CAS  Google Scholar 

  13. Rockwood K. Epidemiological and clinical trials evidence about a preventive role for statins in Alzheimer’s disease. Acta Neurol Scand Suppl. 2006;185: 71–7

    Article  PubMed  CAS  Google Scholar 

  14. Simons M, Schwarzler F, Lutjohann D, von Bergmann K, Beyreuther K, Dichgans J, Wormstall H, Hartmann T, Schulz JB. Treatment with simvastatin in normocholesterolemic patients with Alzheimer’s disease: A 26-week randomized, placebo-controlled, double-blind trial. Ann Neurol. 2002;52: 346–50

    Article  PubMed  CAS  Google Scholar 

  15. Sparks DL, Sabbagh MN, Connor DJ, Lopez J, Launer LJ, Browne P, Wasser D, Johnson-Traver S, Lochhead J, Ziolwolski C. Atorvastatin for the treatment of mild to moderate Alzheimer disease: preliminary results. Arch Neurol. 2005;62: 753–7

    Article  PubMed  Google Scholar 

  16. Gustafson D, Rothenberg E, Blennow K, Steen B, Skoog I. An 18-year follow-up of overweight and risk of Alzheimer disease. Arch Intern Med 2003;163: 1524–8.

    Article  PubMed  Google Scholar 

  17. Kivipelto M, Ngandu T, Fratiglioni L, Viitanen M, Kåreholt I, Winblad B, Helkala E-L, Tuomilehto J, Soininen H, Nissinen A, Obesity and vascular risk factors at midlife and the risk of dementia and Alzheimer’s disease. Arch Neurol 2005; 62: 1556–1560

    Article  PubMed  Google Scholar 

  18. Luchsinger JA and Mayeux R. Dietary factors and AD. Lancet Neurology 2004

  19. Laitinen M, Ngandu T, Rovio S, et al. Fat Intake at Midlife and Risk of Dementia and Alzheimer’s Disease: A Population-based Study. Dement Ger Cogn Disord 2006;22: 99–107

    Article  CAS  Google Scholar 

  20. Calon F, Lim GP, Yang F, Morihara T, Teter B, Ubeda O, Rostaing P, Triller A, Salem N Jr, Ashe KH, Frautschy SA, Cole GM. Docosahexaenoic acid protects from dendritic pathology in an Alzheimer’s disease mouse model. Neuron. 2004;43(5): 633–45

    Article  PubMed  CAS  Google Scholar 

  21. Oksman M, Iivonen H, Hogyes E, Amtul Z, Penke B, Leenders I, Broersen L, Lutjohann D, Hartmann T, Tanila H. Impact of different saturated fatty acid, polyunsaturated fatty acid and cholesterol containing diets on beta-amyloid accumulation in APP/PS1 transgenic mice. Neurobiol Dis. 2006;23(3): 563–72

    Article  PubMed  CAS  Google Scholar 

  22. Freund-Levi Y, Eriksdotter-Jonhagen M, Cederholm T, Basun H, Faxen-Irving G, Garlind A, Vedin I, Vessby B, Wahlund LO, Palmblad J. Omega-3 fatty acid treatment in 174 patients with mild to moderate Alzheimer disease: OmegAD study: a randomized double-blind trial. Arch Neurol. 2006; 63(10): 1402–8

    Article  PubMed  Google Scholar 

  23. Scarmeas N, Stern Y, Mayeux R, Luchsinger JA. Mediterranean diet, Alzheimer disease, and vascular mediation. Arch Neurol. 2006;63(12): 1709–17

    Article  PubMed  Google Scholar 

  24. Fratiglioni L, Paillard-Borg S, Winblad B. An active and socially integrated lifestyle in late life might protect against dementia. Lancet Neurol. 2004;3(6): 343–53

    Article  PubMed  Google Scholar 

  25. Rovio S, Kåreholt I, Helkala E-L, et al. Leisure Time Physical Activity at Midlife and the Risk of Dementia and Alzheimer’s Disease. Lancet Neurol 2005;4: 705–710

    Article  PubMed  Google Scholar 

  26. Colcombe, SJ, Kramer, AF, Erickson, Kl et al. Cardiovascular fitness, cortical plasticity, and aging. Proc Natl Acad Sci USA 2004;101(9): 3316–3321

    Article  PubMed  CAS  Google Scholar 

  27. Berchtold, NC., Kesslak, JP, Cotman CW. Hippocampal brain-derived neurotrophic factor gene regulation by exercise and the medial septum. J Neurosci Res 2002;68: 511–521

    Article  PubMed  CAS  Google Scholar 

  28. Tong, L, Shen, H, Perreau, VM, Balazs, R, Cotman, CW. Effects of exercise on gene-expression profile in the rat hippocampus. Neurobiol Dis 2001;8: 1046–1056

    Article  PubMed  CAS  Google Scholar 

  29. Kramer A, Hahn S, Cohen NJ, et al. Ageing, fitness and neurocognitive function. Nature 1999;400: 418–419

    Article  PubMed  CAS  Google Scholar 

  30. Mukamal KJ, Longstreth WT Jr, Mittleman MA, Crum RM, Siscovick DS. Alcohol consumption and subclinical findings on magnetic resonance imaging of the brain in older adults: the cardiovascular health study. Stroke 2001;32(9): 1939–46

    Article  PubMed  CAS  Google Scholar 

  31. Ding J, Eigenbrodt ML, Mosley TH Jr, Hutchinson RG, Folsom AR, Harris TB, Nieto FJ. Alcohol intake and cerebral abnormalities on magnetic resonance imaging in a community-based population of middle-aged adults: the Atherosclerosis Risk in Communities (ARIC) study. Stroke 2004;35(1): 16–21

    Article  PubMed  Google Scholar 

  32. Cedazo-Minguez A, Cowburn RF. Apolipoprotein E: a major piece in the Alzheimer’s disease puzzle. J Cell Mol Med 2001;5: 254–266

    Article  PubMed  CAS  Google Scholar 

  33. Kivipelto M, Ngandu T, Laatikainen T, Winblad B, Soininen H, Tuomilehto J. Risk Score for prediction of dementia risk in 20 years among middle aged people: a longitudinal population based study. Lancet Neurology 2006;9: 735–41

    Article  Google Scholar 

  34. Whitmer RA, Barnes D, Kivipelto M, Quesenberry CP, Ngandu T, Yaffe K. A midlife risk score for the prediction of dementia more than three decades later. Alzheimer’s and dementia 2007; 3(3) Suppl 2,O1-02-06, S170

    Article  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Aging Research Center, Department of Neurobiology, Caring Sciences and Society (NVS), Karolinska Instituted, Stockholm, Sweden

    M. Kivipelto & A. Solomon

  2. Department of Neurology, University of Kuopio, Finland

    M. Kivipelto & A. Solomon

Authors
  1. M. Kivipelto
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. A. Solomon
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to M. Kivipelto.

Rights and permissions

Reprints and permissions

About this article

Cite this article

Kivipelto, M., Solomon, A. Alzheimer’s disease — The ways of prevention. J Nutr Health Aging 12 (Suppl 1), S89–S94 (2008). https://doi.org/10.1007/BF02982595

Download citation

  • Received:

  • Accepted:

  • Issue Date:

  • DOI: https://doi.org/10.1007/BF02982595

Key words

Search

Navigation